SCHEMBL25165704

SCHEMBL25165704

NCC12CCCCN1CCCC2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.37
GAA P10253 1/20 0.37
RAD52 P43351 1/20 0.37
MEN1 O00255 2/20 0.33
SIGMAR1 Q99720 3/20 0.32
MC4R P32245 1/20 0.32
RAB9A P51151 1/20 0.31
POLB P06746 1/20 0.31
NPC1 O15118 1/20 0.31
HTT P42858 1/20 0.30
GRIN2D O15399 1/20 0.30
GRIN3B O60391 1/20 0.30
CYP2B6 P20813 1/20 0.30
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30
PRCP P42785 1/20 0.30
SLC6A3 Q01959 1/20 0.30
GRIN1 Q05586 1/20 0.30
KCNH2 Q12809 1/20 0.30
GRIN2A Q12879 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8265735 1.00 KMT2A (0.37) KMT2AGAARAD52MEN1SIGMAR1
SCHEMBL553125 0.97 KMT2A (0.36) KMT2AGAARAD52MEN1SIGMAR1
SCHEMBL31441143 0.97 KMT2A (0.36) KMT2AGAARAD52MEN1SIGMAR1
SCHEMBL3930544 0.97 KMT2A (0.36) KMT2AGAARAD52MEN1SIGMAR1
SCHEMBL16757065 0.97 KMT2A (0.36) KMT2AGAARAD52MEN1SIGMAR1
Hydrochloric Acid SCHEMBL1828960 0.95 OPRM1 (0.35) KMT2AGAARAD52MEN1SIGMAR1
SCHEMBL470816 0.92 KMT2A (0.36) KMT2AGAARAD52MEN1SIGMAR1
SCHEMBL4590548 0.92 GAA (0.38) KMT2AGAARAD52KCNH2
SCHEMBL30699749 0.90 GAA (0.37) KMT2AGAARAD52
SCHEMBL16292102 0.81 GAA (0.51) KMT2AGAARAD52SIGMAR1MC4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023061294-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 再鼎医药(上海)有限公司 2023-04-20 WO disclosed